Here isn’t the complete email chain for your reference. Hope this clarifies all your doubts
On Aug 7, 2018, at 8:09 AM, Vinay Kumar Talla <vinay.talla3286@gmail.com> wrote:
Hello Emile,
Good morning!!
I just thought of checking with you if you have any update regarding below email. Can you please look in to it and reply back at your convenience
Thanks, Vinay
On Aug 6, 2018, at 2:04 PM, Vinay Kumar Talla <vinay.talla3286@gmail.com> wrote:
Thank you very much Emile for your prompt response!!
I read the terms and conditions document and as per that point 5. states the following
Qualified Bidder. BioAmber shall only consider offers from bidders who have provided to PwC a Qualified Bid (each a “Qualified Bidder”);
So what exactly is a qualified bid.
Also is it possible to provide a guesstimate of present value of cash , receivables and stocks ?
Thanks, Vinay
On Aug 6, 2018, at 9:10 AM, emile.liu@ca.pwc.com wrote:
Good morning Vinay,
1. In the latest report it is mentioned that the terms and conditions to place a bid will be finalized shortly so can you please let me know few of them which are mandatory to place a bid Please see attached document for the terms and conditions of the asset sale.
2. Does the liquidation plan includes both tangible and intangible assets or is it only the physical assets that are being liquidated? At this stage, we have included the intangible asset as a separate lot. In the end, we will select the bid combination which maximise cash value. Therefore, if a liquidator decides to bid more for the assets and is only interested in the physical components, then only the physical assets will be liquidated and the intangibles will be discarded.
We believe the intangibles of the company cannot operate independently from the physical facility (Mainly trademark, patents, trade secrets).
3. Also in the previous email you mentioned that solicited parties were asked to bid on different lot so does that mean the company is being broken down in to different lots and sold to maximize the value of the assets? We are open to all combinations. Bidders have the choice to bid on different lots, but if a strategic is still interested in paying more for the overall company, then we will choose that one.
From: Vinay Kumar Talla <vinay.talla3286@gmail.com> To: Emile Liu/CA/FAS/PwC@Americas-CA Date: 2018-08-06 09:28 AM Subject: Re: Bioamber
Hello Emile,
I just got OOO response from Blain. So can you please look in to the below email and reply back whenever feasible.
Thanks, Vinay
On Aug 5, 2018, at 9:50 AM, Vinay Kumar Talla <vinay.talla3286@gmail.com> wrote:
Thank you Blain for your response !!
I have few additional questions
1. In the latest report it is mentioned that the terms and conditions to place a bid will be finalized shortly so can you please let me know few of them which are mandatory to place a bid
2. Does the liquidation plan includes both tangible and intangible assets or is it only the physical assets that are being liquidated?
3. Also in the previous email you mentioned that solicited parties were asked to bid on different lot so does that mean the company is being broken down in to different lots and sold to maximize the value of the assets?
Can you please answer them at your convenience
Thanks, Vinay
On Aug 3, 2018, at 4:23 PM, blain.philippe@ca.pwc.com wrote:
Vinay,
Please find answers to your questions below:
1. Did the bidding process already started or are we going to have some kind of auction on Aug 21st ? It started last Wednesday and there is no auction planned at this point. We will proceed in a similar way that we did for the first solicitation process. We are asking solicited parties to bid on different lot before Aug 21st and will analyse all offers received at the end of the process.
2. Will there be any update on PwC website if you have started to receive bids for purchase ? No update on specific bids will be updated on the Monitor's report as the process is confidential. Website will be updated at the end of the process.
3. Do they need to wait until Aug 21 to announce Buyer if they have any or can they announce as soon as some deal is finalized ? We'll report on the conclusion of the process in our Court report around Aug 28.
Let Emile and myself know if you have any further questions. Regards,
Philippe Blain PwC | Senior Associate, Consulting & Deals T: +1 514 205 5001 ext. 1572 Email: blain.philippe@ca.pwc.com PricewaterhouseCoopers Inc. 1250, boulevard René-Lévesque Ouest, bureau 2500, Montréal QC H3B 4Y1 http://www.pwc.com/ca ----- Forwarded by Philippe Blain/CA/FAS/PwC on 2018-08-03 17:15 -----
From: Martine Mainville/CA/FAS/PwC To: Philippe Blain/CA/FAS/PwC@Americas-CA Date: 2018-08-03 13:56 Subject: Fw: Bioamber
Martine Mainville, CPA, CA, CIRP, LIT PwC | Senior Vice President / Première vice présidente, Consulting & Deals / Conseils et Transactions T: +1 514 205 5305 | F: +1 514 205 5694 Email: martine.mainville@ca.pwc.com Assistant: Cindy Fortin | T: +1 514 205 5001 ext. 2199 PricewaterhouseCoopers Inc., LIT 1250, boulevard René-Lévesque Ouest, bureau 2500, Montréal QC H3B 4Y1 http://www.pwc.com/ca ----- Forwarded by Martine Mainville/CA/FAS/PwC on 2018-08-03 13:55 -----
I just had few questions about the process so can you please answer them at your convenience
1. Did the bidding process already started or are we going to have some kind of auction on Aug 21st ?
2. Will there be any update on PwC website if you have started to receive bids for purchase ?
3. Do they need to wait until Aug 21 to announce Buyer if they have any or can they announce as soon as some deal is finalized ?
If you answer these then it will be really great
Thanks, Vinay
> On Jul 31, 2018, at 9:28 AM, Vinay Kumar Talla <vinay.talla3286@gmail.com> wrote: > > Hello Martine, > > Good morning !! > > I just wanted to check with you if the news which we got yesterday is a legit one and the company is looking for liquidation of assets. > Can you please let me know about it > > Thanks, > Vinay
This e-mail is intended only for the person to whom it is addressed (the "addressee") and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use that a person other than the addressee makes of this communication is prohibited and any reliance or decisions made based on it, are the responsibility of such person. We accept no responsibility for any loss or damages suffered by any person other than the addressee as a result of decisions made or actions taken based on this communication or otherwise. If you received this in error, please contact the sender and destroy all copies of this e-mail.
Ce courriel est strictement réservé à l'usage de la personne à qui il est adressé (le destinataire). Il peut contenir de l'information privilégiée et confidentielle. L'examen, la réexpédition et la diffusion de ce message par une personne autre que son destinataire sont interdits. Nous déclinons toute responsabilité à l'égard des pertes ou des dommages subis par une personne autre que le destinataire par suite de décisions ou de mesures fondées sur le contenu de cette communication ou autrement. Si vous avez reçu ce courriel par erreur, veuillez communiquer avec son expéditeur et en détruire toutes les copies.
This e-mail is intended only for the person to whom it is addressed (the "addressee") and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use that a person other than the addressee makes of this communication is prohibited and any reliance or decisions made based on it, are the responsibility of such person. We accept no responsibility for any loss or damages suffered by any person other than the addressee as a result of decisions made or actions taken based on this communication or otherwise. If you received this in error, please contact the sender and destroy all copies of this e-mail.
Ce courriel est strictement réservé à l'usage de la personne à qui il est adressé (le destinataire). Il peut contenir de l'information privilégiée et confidentielle. L'examen, la réexpédition et la diffusion de ce message par une personne autre que son destinataire sont interdits. Nous déclinons toute responsabilité à l'égard des pertes ou des dommages subis par une personne autre que le destinataire par suite de décisions ou de mesures fondées sur le contenu de cette communication ou autrement. Si vous avez reçu ce courriel par erreur, veuillez communiquer avec son expéditeur et en détruire toutes les copies. <Bioamber_Sale_TaC.pdf>